CRBP
NASDAQ · Biotechnology
Corbus Pharmaceuticals Holdi
$2.75
-0.27 (-8.80%)
Open$2.96
Previous Close$3.01
Day High$3.00
Day Low$2.62
52W High$12.88
52W Low$2.81
Volume—
Avg Volume1.50M
Market Cap71.30M
P/E Ratio—
EPS$-6.17
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+342.6% upside
Current
$2.75
$2.75
Target
$12.15
$12.15
$8.71
$12.15 avg
$17.60
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 72.40M | 73.75M | 70.02M |
| Net Income | -2,537,554 | -2,715,843 | -3,439,667 |
| Profit Margin | -3.5% | -3.7% | -4.9% |
| EBITDA | -3,891,696 | -4,515,140 | -4,413,459 |
| Free Cash Flow | -4,239,895 | -2,837,667 | -3,192,005 |
| Rev Growth | +4.2% | -7.8% | -7.0% |
| Debt/Equity | 0.37 | 0.31 | 0.36 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $283.54 | -0.86% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $438.82 | -1.14% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $166.53 | -1.45% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $520.66 | -2.94% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $923.34 | -2.35% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $147.82 | -1.06% | 7.7 | 20.98B |